JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, J. O.
Right arrow Articles by Arvin, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, J. O.
Right arrow Articles by Arvin, A. M.

 Previous Article  |  Next Article 

Journal of Virology, June 2006, p. 5113-5124, Vol. 80, No. 11
0022-538X/06/$08.00+0     doi:10.1128/JVI.01956-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Inhibition of the NF-{kappa}B Pathway by Varicella-Zoster Virus In Vitro and in Human Epidermal Cells In Vivo

Jeremy O. Jones* and Ann M. Arvin

Departments of Pediatrics and Microbiology & Immunology, Stanford University, Stanford, California 94305

Received 14 September 2005/ Accepted 14 March 2006

Varicella-zoster virus (VZV) is an alphaherpesvirus that causes varicella and herpes zoster. Using human cellular DNA microarrays, we found that many nuclear factor kappa B (NF-{kappa}B)-responsive genes were down-regulated in VZV-infected fibroblasts, suggesting that VZV infection inhibited the NF-{kappa}B pathway. The activation of this pathway causes a cellular antiviral response, including the production of alpha/beta interferon, cytokines, and other proteins that restrict viral infection. In these experiments, we demonstrated that VZV interferes with NF-{kappa}B activation in cultured fibroblasts and in differentiated epidermal cells in skin xenografts of SCIDhu mice infected in vivo. VZV infection of fibroblasts caused a transient nuclear translocation of p50 and p65, the canonical NF-{kappa}B family members. In a process that was dependent upon the presence of infectious VZV, these proteins rapidly became sequestered in the cytoplasm of VZV-infected cells. Exclusion of NF-{kappa}B proteins from nuclei was associated with the continued presence of I{kappa}B{alpha}, which binds p50 and p65 and prevents their nuclear accumulation. I{kappa}B{alpha} levels did not diminish even though the protein became phosphorylated and ubiquitinated, as determined based on detection of the characteristic high-molecular-weight form of the protein, and the 26S proteasome remained functional in VZV-infected cells. VZV infection also inhibited the characteristic degradation of I{kappa}B{alpha} that is induced by exposure of fibroblasts to tumor necrosis factor alpha. As expected, herpes simplex virus 1 caused the persistent nuclear translocation of NF-{kappa}B proteins, which has been shown to facilitate its replication, whereas VZV infection progressed without persistent NF-{kappa}B nuclear localization. We suggest that VZV has evolved a mechanism to limit host cell antiviral defenses by sequestering NF-{kappa}B proteins in the cytoplasm, a strategy that appears to be unique among the herpesviruses.


* Corresponding author. Mailing address: Stanford University School of Medicine, 300 Pasteur Drive, Rm. G312, Stanford, CA 94305-5208. Phone: (650) 725-6555. Fax: (650) 725-8040. E-mail: jeremy.jones{at}ucsf.edu.


Journal of Virology, June 2006, p. 5113-5124, Vol. 80, No. 11
0022-538X/06/$08.00+0     doi:10.1128/JVI.01956-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.